Navigation Links
Amylin Pharmaceuticals to Present at the Deutsche Bank 36th Annual Healthcare Conference
Date:4/27/2011

SAN DIEGO, April 27, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank 36th Annual Healthcare Conference on Wednesday, May 4, 2011 at 12:15 p.m. ET / 9:15 a.m. PT in Boston. Mark Foletta, senior vice president, finance and chief financial officer at Amylin Pharmaceuticals, will provide a corporate overview.

The presentation will be webcast live through the "Investors" section of Amylin's corporate website at www.amylin.com, and a recording will be made available on the website following the event. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amylin Pharmaceuticals Reports First Quarter Financial Results
2. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
3. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
4. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
5. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
6. Amylin Pharmaceuticals Reports 2010 Financial Results
7. Amylin Pharmaceuticals to Webcast Year-End Financial Results
8. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
10. Amylin Pharmaceuticals Reports Third Quarter Financial Results
11. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... CLEVELAND , April 26, 2016 ... is forecast to expand 4.9 percent annually to ... and other healthcare facilities to decrease rates of ... infection prevention supplies, equipment, and services.  Although declining, ... is significantly above targeted levels set by the ...
(Date:4/26/2016)... Bayer AG has reported first-quarter ... and amortization. The earnings are the result of a ... Xarelto and Eylea, drugs Bayer is banking on to ... date was extended by four years this week to ... to reach a value of USD 1,147.1 billion ...
(Date:4/26/2016)... , April 26, 2016 ... Microbial identification Market Size, Share, Development, Growth ... Insights by Product (Consumables, Instruments and Software ... Genotypic Method), by Application (Diagnostic Application, Food ... Application) and by End User (Hospitals, Pharmaceutical ...
Breaking Medicine Technology:
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy ... prescription medications from over 180 American pharmaceutical companies for $35 per month, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... offering, the Protocol Calendar Exchange , is officially open to all sponsors ... calendars available for sites to download into their clinical trial management system (CTMS), ...
(Date:4/28/2016)... ... 2016 , ... On Thursday, April 14 orthopaedic surgeon ... Institute in Vail, Colorado, attended the American Academy of Orthopaedic Surgeons (AAOS) ... musculoskeletal disorders that are affecting millions of Americans today. Dr. LaPrade and many ...
(Date:4/28/2016)... Valley, California (PRWEB) , ... ... ... Inc. (AGNITY) a leading global provider of intelligent business communication applications and ... and go-live of its Number Portability solution at Bestel’s Communications Network. ...
Breaking Medicine News(10 mins):